Effects of as-if risk framing of hazards on risk perception and its rebuttal.

Framing Hazard identification Rebuttal Risk assessment Risk characterization Risk communication Risk perception

Journal

Regulatory toxicology and pharmacology : RTP
ISSN: 1096-0295
Titre abrégé: Regul Toxicol Pharmacol
Pays: Netherlands
ID NLM: 8214983

Informations de publication

Date de publication:
Dec 2022
Historique:
received: 03 08 2022
revised: 05 10 2022
accepted: 24 10 2022
pubmed: 4 11 2022
medline: 30 11 2022
entrez: 3 11 2022
Statut: ppublish

Résumé

The difference between hazard and risk is crucial in risk assessment but rather unknown by non-experts. Hyper-partisan activists could use this knowledge gap to amplify risk perception by framing hazards as as-if risks, i.e., describing hazards as if their exposure is critical. Thus, using this as-if risk framing can trigger impressions that a risk is present. Until now, this framing technique and its rebuttal was not empirically analyzed. An experimental 2 × 2 factorial online study (N = 404) with repeated measures after intervention was conducted to investigate how framing (hazard vs. as-if risk) and stigmatization (stigmatized vs. non-stigmatized chemical agent) affects affective and cognitive risk perception using an example of exposure to drifting pesticides. As-if risk framing increased risk perception, effects of stigmatization were not observed. However, the a-priori risk perception influences the recorded risk perceptions after the experimental treatment. Rebuttal was successful, i.e., subjects with elevated risk perceptions due to as-if risk framing reduced their risk perception after receiving corrective information. As-if risk framing investigated here is not a sequestered case. Accordingly, the present study may offer general insights into correcting biased information that neglects the difference between hazard and risk. Risk communicators can benefit from these insights.

Sections du résumé

BACKGROUND BACKGROUND
The difference between hazard and risk is crucial in risk assessment but rather unknown by non-experts. Hyper-partisan activists could use this knowledge gap to amplify risk perception by framing hazards as as-if risks, i.e., describing hazards as if their exposure is critical. Thus, using this as-if risk framing can trigger impressions that a risk is present. Until now, this framing technique and its rebuttal was not empirically analyzed.
METHOD METHODS
An experimental 2 × 2 factorial online study (N = 404) with repeated measures after intervention was conducted to investigate how framing (hazard vs. as-if risk) and stigmatization (stigmatized vs. non-stigmatized chemical agent) affects affective and cognitive risk perception using an example of exposure to drifting pesticides.
RESULTS RESULTS
As-if risk framing increased risk perception, effects of stigmatization were not observed. However, the a-priori risk perception influences the recorded risk perceptions after the experimental treatment. Rebuttal was successful, i.e., subjects with elevated risk perceptions due to as-if risk framing reduced their risk perception after receiving corrective information.
CONCLUSIONS CONCLUSIONS
As-if risk framing investigated here is not a sequestered case. Accordingly, the present study may offer general insights into correcting biased information that neglects the difference between hazard and risk. Risk communicators can benefit from these insights.

Identifiants

pubmed: 36328135
pii: S0273-2300(22)00169-6
doi: 10.1016/j.yrtph.2022.105282
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

105282

Informations de copyright

Copyright © 2022. Published by Elsevier Inc.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Peter Michael Wiedemann (PM)

Department of Epidemiology and Preventive Medicine, School of Public Health and Preventive Medicine, Faculty of Medicine Nursing and Health Sciences, Monash University, Melbourne, VIC, Australia.

Fabian Kirsch (F)

Department of Risk Communication, German Federal Institute for Risk Assessment, Berlin, Germany.

Mark Lohmann (M)

Department of Risk Communication, German Federal Institute for Risk Assessment, Berlin, Germany.

Gaby-Fleur Böl (GF)

Department of Risk Communication, German Federal Institute for Risk Assessment, Berlin, Germany.

Frederik Freudenstein (F)

Department of Epidemiology and Preventive Medicine, School of Public Health and Preventive Medicine, Faculty of Medicine Nursing and Health Sciences, Monash University, Melbourne, VIC, Australia. Electronic address: frederik.freudenstein@monash.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH